Catégories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
716
Aroma Chemicals
203
Biochemicals
1004
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
Lopinavir
(89983914 | 192725-17-0)
CAS: | 192725-17-0 |
---|---|
Formule moléculaire: | C37H48N4O5 |
Masse moléculaire: | 628.80 |
Disponibilité: | En stock |
---|---|
Téléchargements: |
89983914-250mg | 250mg | £62.10 | |
Commande en vrac |
89983914-250mg | 250mg | €87.00 | |
Commande en vrac |
89983914-250mg | 250mg | $93.20 | |
Commande en vrac |
spécification
Certificat d'analyse
Détails du produit
Product Code | 89983914 | ||||
Product Name | Lopinavir | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 192725-17-0 | ||||
Molecular Formula | C37H48N4O5 | ||||
Molecular Weight | 628.80 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29335995 |
Spécifications du produit
Specific rotation | -22° to -26° | ||||
Heavy metals | ≤ 20 ppm | ||||
Identification | Conforms to reference (IR,HPLC) | ||||
Residue on Ignition | <0.2% | ||||
Sulfated ash | ≤ 0.2% | ||||
Appearance | White to off white powder | ||||
Water content ( KF) | ≤ 4.0% | ||||
Assay (HPLC ) | 98% -102% | ||||
Version | To report |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|